Gastrointestinal Cancer RTOG 0848

March 13, 2013

Location: The Hospital of Central Connecticut

A Phase III Trial Evaluating both Erotinib and Chemoradiation as Adjuvant Treatment for Patients with Resected Head of Pancreas Adenocarcinoma.